Company intelligence / Profile preview

IDG-Accel China Growth Fund II

Beijing, China

Ownership: Private
Development stage: Other

Overview

IDG-Accel China Growth Fund II is a $250 million growth-stage venture capital fund managed by IDG Technology Venture Investment LLC (IDGVC), focusing on investments in information technology, healthcare, consumer technologies, and emerging sectors in China. Its portfolio includes companies like Accutar Biotech and OriGene Technologies.

Industry: Investors

Beyond the preview

Go deeper on IDG-Accel China Growth Fund II.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IDG-Accel China Growth Fund II.

Explore the full profile